The activity of tiotropium on TRPV1 might be responsible, at least in part, for some of the clinical benefit associated with taking it and might suggest alternative applications for this compound outside of COPD in respiratory and nonrespiratory disorders in which cough is a major debilitating symptom. Here, TRPV1 is linked to chronic obstructive pulmonary disease.